November 01, 2025

Get In Touch

Ex-Fortis Promoters Malvinder, Shivinder Sent To 14-Day Judicial Custody

Delhi Court Remands Former Fortis Healthcare Promoters

Delhi Court Remands Former Fortis Healthcare Promoters

A Delhi court Thursday remanded former Fortis Healthcare promoters Malvinder Singh and his brother Shivinder to 14-day judicial custody for allegedly misappropriating funds of Religare Finvest Ltd (RFL).

Metropolitan Magistrate Nishant Garg also sent three others, Sunil Godhwani, Kavi Arora, and Anil Saxena, to judicial custody till October 31.

The Singh brothers had moved a bail plea which will be heard, along with that of Arora, on Friday.

Also read: Don’t owe any money to Singh Brothers’ Company: Radha Soami Chief tells High Court

The Economic Offences Wing (EOW) of Delhi Police had on Tuesday told the court that Singh brothers have disclosed that an amount of about Rs 1,000 crore has been transferred to various persons from the entities linked to corporate loan book which was then allegedly siphoned off.

The investigating officer of the Delhi Police (EOW), in the remand application, had sought custodial interrogation of the accused saying it was required to identify the persons to whom the alleged siphoned off money was transferred and to ascertain the purpose of creating the shell companies.

The police plea stated that custodial interrogation was required to confront the directors of the shell entities with the accused with respect to their association.

Counsel for Malvinder did not oppose the plea, saying investigation conducted so far has brought forth material which may also benefit the accused, adding that he already shown some links to the police with regard to where his money has gone.

Malvinder (46), Shivinder (44), Godhwani (58), Arora (48), and Saxena, were arrested by the EOW for allegedly diverting the money and investing in other companies.

The court had on Tuesday extended by two days the police custody of Singh brothers and Godhwani after the probe agency sought their custody saying that new material has come up in the case. Arora and Saxena, were also sent to 2-day judicial custody by the court.

Senior advocate Vikas Pahwa, appearing for RFL's Manpreet Singh Suri, who filed the complaint in December last year, had earlier alleged that the case was a serious economic offence.

Religare has accused them of diverting funds, claiming that loans were taken by Shivinder while managing the firm but the money was invested in other companies.

The police had said that the accused have to be confronted with other officials to ascertain the role of co-conspirators and said that the money trail was to be found in the case which was at an initial stage of probe.

The counsel for Malvinder had earlier told the court that the money was with Radha Soami head Gurinder Singh Dhillon but the police was not going after him since he had political connections and that Malvinder was being made a soft target.

RFL is a subsidiary of the REL. Malvinder and Shivinder were earlier the promoters of REL.

The police had said that a look out circular (LOC) had been issued against Malvinder as he was absconding.

Also read: Singh brothers, 3 others arrested for massive Rs 2400 crore fund misappropriation in Religare

The EOW had registered an FIR in March after it received a complaint from Suri against Shivinder, Godhwani, and others alleging that loans were taken by them while managing the firm but the money was invested in other companies.

According to the police, the complainant stated that the four had absolute control on REL and its subsidiaries.

"They put RFL in poor financial condition by disbursing loans to companies having no financial standing and being controlled by them. The companies to which loans were disbursed willfully defaulted in repayments and caused a loss to RFL to the tune of Rs 2,397 crore," police had alleged.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!